MIT is Developing an All-In-One Means of Diabetes Treatment
Current diabetes management is far from practical. In order to avoid a dangerous blood sugar spike after mealtime, diabetes patients have to inject themselves with insulin. This can only be performed once the patient has drawn blood to measure their glucose levels, and calculated the correct insulin dosage based on the estimated amount of carbohydrates they’ll be consuming. Without the assistance of widely-inaccessible continuous blood glucose monitors and insulin pumps, the process relies heavily on the patient’s dexterity and ability to plan ahead. Even for someone committed to managing their diabetes, this clunky form of treatment can be difficult to stick to long-term.
A more streamlined approach like the one Traverso’s team is developing may aid in the long-term success of at-home diabetes management. According to the study published in the Journal of Controlled Release, there are two different devices in the pipeline: one that consolidates several steps of the above process into one task, and one that marries blood sugar measurement and insulin delivery on one needle. Both work in tandem with a smartphone app—also developed by MIT—that identifies and quantifies carbohydrate content in food.
The first device combines a lancet (used to draw blood) and glucose testing strips into one tool, which measures and conveys a patient’s blood sugar level to MIT’s smartphone app via Bluetooth. The app then calculates the patient’s ideal insulin dose and delivers it using an included needle.
The second device reduces the patient’s potential discomfort down to one needle prick. Traverso and his colleagues developed a flexible electronic glucose sensor that could be incorporated into the same needle used for insulin injection. The needle takes a maximum of ten seconds to measure the patient’s glucose level; it then transmits that data to the smartphone app to calculate the right dose of insulin and deliver it to the patient.
Traverso’s team has filed for patents on both devices. Each has been tested on pigs but not on humans, and given the novelty of the newly-developed glucose sensor, the second device will require further development before it finds its way into patients’ hands.
Continue reading
5-Day Stimulation Treatment Effective Against Depression
Researchers at Stanford University appear to have found a way to treat persistent depression using magnetic brain stimulation.
Frogs Regrow Limb With New Treatment
The study’s results show promise for the future of regeneration research as it relates to amputated limbs.
AI Discovery Could Improve Treatment of Spinal Cord Injuries
The stabilization of certain enzymes appears to break down scar tissue, allowing the nervous system to communicate freely once again.
Researchers Create Microbial Treatment to Protect the Gut from Antibiotics
The side effects usually associated with antibiotics can make patients feel like they're replacing one health issue with another.